article Open AccessTop 1% cited
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
American Journal Of Pathology · 1999 · Vol. 155(3) · pp. 853–862
Lih-Fen Lue✉(Banner Sun Health Research Institute)Yu‐Min Kuo(Banner Sun Health Research Institute)Alex E. Roher(Banner Sun Health Research Institute)Libuse Brachova(Banner Sun Health Research Institute)Yong Shen(Banner Sun Health Research Institute)Lucia I. Sue(Banner Sun Health Research Institute)Thomas G. Beach(Banner Sun Health Research Institute)Janice KurthRussel E. RydelJoseph Rogers(Banner Sun Health Research Institute)
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative DiseasesCerebral amyloid angiopathySenile plaquesAlzheimer's diseaseAmyloid (mycology)DementiaPathologySynapseThioflavinApolipoprotein ENeurodegeneration
MeSH terms
Cerebral Amyloid AngiopathyAgedAged, 80 and overAlzheimer DiseaseApolipoproteins EBrainDiagnosis, DifferentialFemaleGene FrequencyHumansImmunohistochemistryMalePeptide FragmentsPredictive Value of TestsSynapses
Citations
1,521
FWCI
15.35
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Cited by
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
Science · 2002 · 13,715 citations
Protein Misfolding, Functional Amyloid, and Human Disease
Annual Review of Biochemistry · 2006 · 6,373 citations
High-Level Neuronal Expression of Aβ<sub>1–42</sub>in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
Journal of Neuroscience · 2000 · 1,860 citations
Amyloid-β oligomers: their production, toxicity and therapeutic inhibition
Biochemical Society Transactions · 2002 · 514 citations
Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease
Journal of Neuroscience Research · 2016 · 432 citations
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Nature Medicine · 2008 · 3,621 citations
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease
Acta Neuropathologica · 2009 · 735 citations
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
Neurobiology of Aging · 2001 · 510 citations
References
Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Journal of Neuroscience Research · 1994 · 483 citations
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Annals of Neurology · 1991 · 4,370 citations
Neuropathological stageing of Alzheimer-related changes
Acta Neuropathologica · 1991 · 16,076 citations
Identification of normal and pathological aging in prospectively studied nondemented elderly humans
Neurobiology of Aging · 1992 · 640 citations
Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques
Annals of Neurology · 1988 · 1,224 citations
Quantitative assessment of cortical synaptic density in Alzheimer's disease
Neurobiology of Aging · 1990 · 447 citations
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Journal of Lipid Research · 1990 · 2,943 citations
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Neurology · 1991 · 5,023 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.